Search

Your search keyword '"Schmitz, Manuela"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Schmitz, Manuela" Remove constraint Author: "Schmitz, Manuela"
19 results on '"Schmitz, Manuela"'

Search Results

1. Additional file 3 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

2. Additional file 8 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

3. Additional file 5 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

5. Additional file 2 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

6. Additional file 7 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

7. Additional file 4 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

8. Additional file 9 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

9. Additional file 6 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

12. High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials

15. Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases.

17. In routine clinical practice, few physicians use early viral kinetics to guide HCV dual therapy treatment decisions

18. Treatment Outcomes and Predictors of Response in Treatment-Naive HCV Patients Treated with Peginterferon Alfa/Ribavirin in Real-World Italian Clinics: Sub-Analysis from the PROPHESYS Cohort.

19. SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: results from the real world PROPHESYS study.

Catalog

Books, media, physical & digital resources